@article{2ddc30155afd46cd87dec21b6ce1c925,
title = "The Truth Is Unfolding About Transthyretin Cardiac Amyloidosis",
keywords = "Editorials, amyloidosis, hereditary, cardiomyopathies, quality of life",
author = "Grodin, {Justin L.} and Maurer, {Mathew S.}",
note = "Funding Information: Dr Grodin receives grant support from the Texas Health Resources Clinical Scholarship. Dr Maurer receives grant support from National Institutes of Health grants R01HL139671-01, R21AG058348, and K24AG036778. Funding Information: Dr Grodin receives consulting income from Pfizer. Dr Maurer receives consulting income from Pfizer, GSK, Eidos, Prothena, Akcea, and Alnylam, and his institution received clinical trial funding from Pfizer, Prothena, Eidos, and Alnylam.",
year = "2019",
month = jul,
day = "2",
doi = "10.1161/CIRCULATIONAHA.119.041015",
language = "English (US)",
volume = "140",
pages = "27--30",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "1",
}